Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Drive Therapeutics logo — Addressing Unmet Needs in Retinal Therapeutics

Drive Therapeutics

Addressing Unmet Needs in Retinal Therapeutics

Founded 2019 United States United States 3 employees Grant Total: $431.00K Biotechnology, Health Care +1

General Information

Company Name Drive Therapeutics
Founded Year 2019
Location United States United States
Founders / Decision Makers
Team member
Employees 3
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Drive Therapeutics. To contact Drive Therapeutics, visit drivetherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Drive Therapeutics compare?

A PDF of Drive Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Drive Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Drive Therapeutics

Drive Therapeutics is a biotechnology startup founded in 2019 with the aim of addressing unmet needs in retinal therapeutics. The company's slogan "Addressing Unmet Needs in Retinal Therapeutics" reflects its commitment to tackling critical issues in the health care industry. Despite a relatively short history, Drive Therapeutics has already attracted attention and secured a notable $75.00K grant investment from the One North Carolina Small Business Program on 22 September 2022. This investment signifies a vote of confidence in the company's potential to make a meaningful impact in the field. With its headquarters in the United States, Drive Therapeutics is poised to make significant strides in the biotechnology sector. As the company continues to develop its strategies and offerings, the industry and investors alike should stay tuned for further updates on Drive Therapeutics' progress.

Business keywords: retinal therapeutics, ophthalmology, biopharmaceutical, innovation, startup, investor, clinical trials, ophthalmic research, vision care, drug development, biomedical advancements

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $75.00K 1
One North Carolina Small Business Program
22 Sep 2022
Grant $256.00K 1
National Science Foundation
National Science Foundation
27 Jul 2021
Debt Financing $100.00K 1
North Carolina Biotechnology Center
03 Feb 2021

Drive Therapeutics Alternatives & Competitors

View All Alternatives
Drive Therapeutics vs
Perceive Biotherapeutics, Inc.
Perceive Biotherapeutics, Inc. United States

A start-up developing novel ophthalmic therapeutics to treat major unmet needs for patients. PLEASE...

Series B
20 employees
Biopharma, Biotechnology
Drive Therapeutics vs
Aurion Biotech
Aurion Biotech United States

We're on a mission to cure blindness with our transformational platform of advanced therapies

Acquired
94 employees
Biopharma, Biotechnology
Drive Therapeutics vs
Palatin Technologies
Palatin Technologies

We discover and develop novel therapeutics for patients living with inflammatory and autoimmune cond...

Post-IPO Equity
50 employees
Biotechnology, Health Care
View all alternatives

FAQ About Drive Therapeutics

Addressing Unmet Needs in Retinal Therapeutics
Drive Therapeutics was founded in 2019.
Drive Therapeutics is headquartered in United States.
Drive Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on retinal therapeutics, ophthalmology, biopharmaceutical and innovation.
Drive Therapeutics has approximately 3 employees.
Drive Therapeutics has completed 3 funding rounds, raising a total of $431.00K. The latest funding stage is Grant.
Top alternatives and competitors to Drive Therapeutics include Perceive Biotherapeutics, Inc., Aurion Biotech, Palatin Technologies, Phoenix Molecular Designs, ONL Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Drive Therapeutics and Perceive Biotherapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Drive Therapeutics, https://bouncewatch.com/company/drive-therapeutics, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes